Literature DB >> 19054149

Multicentric occurrence and spread of hepatocellular carcinoma in whole explanted end-stage liver.

Masaaki Hidaka1, Susumu Eguchi, Sadayuki Okudaira, Mitsuhisa Takatsuki, Hirotaka Tokai, Akihiko Soyama, Shigeki Nagayoshi, Satoshi Mochizuki, Koji Hamasaki, Yoshitsugu Tajima, Takashi Kanematsu.   

Abstract

AIM: Hepatocellular carcinoma (HCC) arising from the end stages of liver cirrhosis is a fair indication for liver transplantation (LT). To pathologically investigate the multicentric occurrence of relatively early staged HCC in cirrhosis, we studied whole explanted livers.
METHODS: Fourteen explanted livers from patients undergoing living donor LT (LDLT) were examined. The stage of the HCCs was judged to be within the Milan criteria (M-C; a single HCC less than 5 cm or three HCCs less than 3 cm). Histological examination was performed using serially sectioned specimens 5-7 mm in width. Characterization of preoperatively detectable and undetectable lesions was also performed.
RESULTS: In nine patients (64.3%), a total of 34 nodules were found after whole liver histological examination (WLHE). In five patients (31%), the results exceeded the M-C. The characteristics of undetectable HCCs included a minute (median size 6 mm), well-differentiated appearance (80%), with indistinct margins (85.3%) and without vascular invasion (94%). There was no recurrence in any patients at the time of follow up (median follow-up period, 30.1 months).
CONCLUSION: A multicentric occurrence of HCCs was demonstrated in cirrhotic livers with HCCs within the M-C. Undetectable HCCs in cirrhotic livers may have no impact on recurrence after LT.

Entities:  

Year:  2008        PMID: 19054149     DOI: 10.1111/j.1872-034X.2008.00443.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  4 in total

1.  Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.

Authors:  Susumu Eguchi; Mitsuhisa Takatsuki; Masaaki Hidaka; Akihiko Soyama; Tetsuo Tomonaga; Izumi Muraoka; Takashi Kanematsu
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

2.  The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver.

Authors:  Masaaki Hidaka; Mitsuhisa Takatsuki; Sadayuki Okudaira; Akihiko Soyama; Izumi Muraoka; Takayuki Tanaka; Izumi Yamaguchi; Takanobu Hara; Hisamitsu Miyaaki; Tatsuki Ichikawa; Tomayoshi Hayashi; Ichiro Sakamoto; Kazuhiko Nakao; Tamotsu Kuroki; Takashi Kanematsu; Susumu Eguchi
Journal:  Hepatol Int       Date:  2012-06-24       Impact factor: 6.047

3.  Actual therapeutic efficacy of pre-transplant treatment on hepatocellular carcinoma and its impact on survival after salvage living donor liver transplantation.

Authors:  Susumu Eguchi; Masaaki Hidaka; Tetsuo Tomonaga; Kensuke Miyazaki; Takamitsu Inokuma; Mitsuhisa Takatsuki; Sadayuki Okudaira; Kosho Yamanouchi; Hisamitsu Miyaaki; Tatsuki Ichikawa; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  J Gastroenterol       Date:  2009-04-21       Impact factor: 7.527

4.  Long-term outcomes of living-donor liver transplantation, hepatic resection, and local therapy for hepatocellular carcinoma with three <3-cm nodules in a single institute.

Authors:  Masaaki Hidaka; Takanobu Hara; Akihiko Soyama; Tomohiko Adachi; Hajime Matsushima; Takayuki Tanaka; Hideki Ishimaru; Hisamitsu Miyaaki; Kazuhiko Nakao; Susumu Eguchi
Journal:  JGH Open       Date:  2022-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.